Highlights Clover Biopharmaceuticals, Ltd.

Equities

2197

KYG2280A1076

Market Closed - Hong Kong S.E. Other stock markets 09:08:09 16/05/2024 BST			5-day change	1st Jan Change
0.47 ^HKD	+5.62%		+11.90%	-24.19%

04-12	Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding	CI
04-08	Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial	04-08	MT
Clover Biopharmaceuticals, Ltd. Announces Positive Preliminary Phase I Results for Bivalent RSV Vaccine Candidate SCB-1019 In Initial Young Adult Cohort	04-08	CI
Clover Biopharmaceuticals Trims Losses in 2023	03-27	MT
Clover Biopharmaceuticals, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Clover Biopharmaceuticals, Ltd. Announces Positive Phase I Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia	12-28	CI
Clover Biopharmaceuticals, Ltd. Initiates Phase Clinical Trial for RSV Vaccine Candidate	12-12	CI
Clover Biopharmaceuticals Completes Submission of Application for Seasonal Flu Vaccine in Brazil	11-07	MT
Clover Biopharmaceuticals, Ltd. Completes Biologic License Application for Its Seasonal Influenza Vaccine in Brazil	11-06	CI
Clover Biopharmaceuticals Rolls Out Quadrivalent Seasonal Influenza Vaccine in Mainland China	12/09/23	MT
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China	11/09/23	CI
Clover Biopharmaceuticals Swings to Profit in H1	23/08/23	MT
Clover Biopharmaceuticals, Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23/08/23	CI
Clover Biopharmaceuticals Expects Swing to Profit in H1	14/08/23	MT
Clover Biopharmaceuticals, Ltd. Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Six Months Ended June 30, 2023	14/08/23	CI
Clover Biopharmaceuticals, Ltd. Provides Updates on Business and R&D Pipeline Development	11/07/23	CI
Clover Biopharmaceuticals to Expand Distribution, Sales of Flu Shot with Keyuan Xinhai Deal	24/05/23	MT
Clover Biopharmaceuticals, Ltd. Establishes Commercial Partnership with Keyuan Xinhai Medical Products Trading Co. Ltd	24/05/23	CI
Clover Biopharmaceuticals' 2022 Loss Narrows; Shares Tumble 9%	29/03/23	MT
Clover Biopharmaceuticals, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	29/03/23	CI
Clover Bio Signs Exclusive Deal to Distribute Influenza Vaccine in China; Shares Climb 3%	20/02/23	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Clover Biopharmaceuticals, Ltd.

Equities

2197

KYG2280A1076

Highlights

Filters